Back to Search
DANIEL HABER, MD PHD
MD PHD
Medical Oncology Physician
NPI: 1952385783Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
54111(MA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
54111(MA)
Research & Publications (20)
Overcoming acquired resistance to Iressa/Tarceva with inhibitors of a different class.
PMID 15970680·Cell Cycle·2005
8-other
Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors.
PMID 16869779·Cold Spring Harb Symp Quant Biol·2005
6-review
The BRCA2-EMSY connection: implications for breast and ovarian tumorigenesis.
PMID 14651841·Cell·2003
6-review
BRCA1: an emerging role in the cellular response to DNA damage.
PMID 10902618·Lancet·2000
7-preclinical
The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients.
PMID 19247082·J Thorac Oncol·2009
8-other
A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression.
PMID 19651985·Genes Dev·2009
7-preclinical
The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity.
PMID 19416806·Proc Natl Acad Sci U S A·2009
8-other
Autoreactivity of serum immunoglobulin to periodontal tissue components: a pilot study.
PMID 19335083·J Periodontol·2009
8-other
Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors.
PMID 19366796·Cancer Res·2009
8-other
Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sites.
PMID 18591665·Proc Natl Acad Sci U S A·2008
8-other
Adenosine transporter ENT4 is a direct target of EWS/WT1 translocation product and is highly expressed in desmoplastic small round cell tumor.
PMID 18523561·PLoS One·2008
8-other
Modeling oncogene addiction using RNA interference.
PMID 18711136·Proc Natl Acad Sci U S A·2008
8-other
Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort.
PMID 18483364·Clin Cancer Res·2008
8-other
First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.
PMID 18458038·J Clin Oncol·2008
3-trial
Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms.
PMID 18593984·Clin Cancer Res·2008
8-other
Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma.
PMID 18559533·Cancer Res·2008
8-other
In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2.
PMID 18797466·Br J Cancer·2008
8-other
Reduced Erlotinib sensitivity of epidermal growth factor receptor-mutant non-small cell lung cancer following cisplatin exposure: a cell culture model of second-line erlotinib treatment.
PMID 18980981·Clin Cancer Res·2008
8-other
Detection of mutations in EGFR in circulating lung-cancer cells.
PMID 18596266·N Engl J Med·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 55 FRUIT ST, 149 7202
BOSTON, MA 02114 - Phone
- (617) 726-7805
Quick Facts
- NPI
- 1952385783
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile